The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Allopurinol Improves Myocardial Efficiency in Patients With Idiopathic Dilated Cardiomyopathy
Abstract
Background Dilated cardiomyopathy is characterized by an imbalance between left ventricular performance and myocardial energy consumption. Experimental models suggest that oxidative stress resulting from increased xanthine oxidase (XO) activity contributes to this imbalance. Accordingly, we hypothesized that XO inhibition with intracoronary allopurinol improves left ventricular efficiency in patients with idiopathic dilated cardiomyopathy. Methods and Results Patients (n=9; ejection fraction, 29±3%) were instrumented to assess myocardial oxygen consumption (MV̇ o 2 ), peak rate of rise of left ventricular pressure (dP/dt max ), stroke work (SW), and efficiency (dP/dt max /MV̇ o 2 and SW/MV̇ o 2 ) at baseline and after sequential infusions of intracoronary allopurinol (0.5, 1.0, and 1.5 mg/min, each for 15 minutes). Allopurinol caused a significant decrease in MV̇ o 2 (peak effect, −16±5%; P <0.01; n=9) with no parallel decrease in dP/dt max or SW and no change in ventricular load. The net result was a substantial improvement in myocardial efficiency (peak effects: dP/dt max /MV̇ o 2 , 22±9%, n=9; SW/MV̇ o 2 , 40±17%, n=6; both P <0.05). These effects were apparent despite concomitant treatment with standard heart failure therapy, including ACE inhibitors and β-blockers. XO and its parent enzyme xanthine dehydrogenase were more abundant in failing explanted human myocardium on immunoblot. Conclusions These findings indicate that XO activity may contribute to abnormal energy metabolism in human cardiomyopathy. By reversing the energetic inefficiency of the failing heart, pharmacological XO inhibition represents a potential novel therapeutic strategy for the treatment of human heart failure.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Extensive evidence supports a role of XO in the development of cardiovascular disease (137, 148, 157, 282, 430, 466, 561, 633).”
From Sources of Vascular Nitric Oxide and Reactive Oxygen Species and Their Regulation (2019) · cites this paper as [148]
In the citing paper
“In small trials, the pharmacological inhibition of XO with allopurinol/oxypurinol improved cardiovascular conditions in several pathologies, including heart failure (58, 278), dilated cardiomyopathy (148), and diabetes (137, 224).”
From Sources of Vascular Nitric Oxide and Reactive Oxygen Species and Their Regulation (2019) · cites this paper as [148]
Citations
Cites
Oxygen-Derived Free Radicals in Postischemic Tissue Injury
Epstein, F. H., & McCord, J. M. (1985) · New England Journal of Medicine · doi:10.1056/nejm198501173120305 · Cited by 5,399
Validation of a Doppler guide wire for intravascular measurement of coronary artery flow velocity.
Doucette, J. W., Corl, P. D., Payne, H. M., Flynn, A. E., Goto, M., Nassí, M., & Segal, J. (1992) · Circulation · doi:10.1161/01.cir.85.5.1899 · Cited by 1,017
Activation of the Cardiac Calcium Release Channel (Ryanodine Receptor) by Poly-S-Nitrosylation
Xu, L., Eu, J. P., Meissner, G., & Stamler, J. S. (1998) · Science · doi:10.1126/science.279.5348.234 · Cited by 991
Effective arterial elastance as index of arterial vascular load in humans.
Kelly, R. P., Ting, C.-T., Yang, T. M., Liu, C. P., Maughan, W. L., Chang, M.-S., & Kass, D. A. (1992) · Circulation · doi:10.1161/01.cir.86.2.513 · Cited by 832
Self-citationSuga, H. (1990) · Physiological Reviews · doi:10.1152/physrev.1990.70.2.247 · Cited by 744
Enroth, C., Eger, B. T., Okamoto, K., Nishino, T., Nishino, T., & Pai, E. F. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.20.10723 · Cited by 733
A Dose-Dependent Increase in Mortality with Vesnarinone among Patients with Severe Heart Failure
Cohn, J. N., Goldstein, S., Greenberg, B., Lorell, B. H., Bourge, R. C., Jaski, B. E., Gottlieb, S. O., McGrew, F. A., DeMets, D. L., & White, B. G. (1998) · New England Journal of Medicine · doi:10.1056/nejm199812173392503 · Cited by 612
Keith, M. E., Geranmayegan, A., Sole, M. J., Kurian, R., Robinson, A., Omran, A., & Jeejeebhoy, K. N. (1998) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(98)00101-6 · Cited by 560
Elevated Levels of 8-iso-Prostaglandin F2αin Pericardial Fluid of Patients With Heart Failure
Mallat, Z., Philip, I., Lebret, M., Chatel, D., Maclouf, J., & Tedgui, A. (1998) · Circulation · doi:10.1161/01.cir.97.16.1536 · Cited by 458
Campbell, D. L., Stamler, J. S., & Strauss, H. C. (1996) · The Journal of general physiology · doi:10.1085/jgp.108.4.277 · Cited by 441
Flagged first, then by citations
Cited by
Sorted by citations
Items 201–300 of 436
Allopurinol and global left myocardial function in heart failure patients
Maurice, C., & Nasr, G. M. (2010) · Journal of Cardiovascular Disease Research · doi:10.4103/0975-3583.74262 · Cited by 35
Zhou, L., Huang, H., Yuan, C. L., Keung, W., Lopaschuk, G. D., & Stanley, W. C. (2007) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00557.2007 · Cited by 35
Treatment for Pulmonary Arterial Hypertension–Associated Right Ventricular Dysfunction
Gomez‐Arroyo, J. G., Sandoval, J., Simon, M. A. M., Dominguez-Cano, E., Voelkel, N. F., & Bogaard, H. J. (2014) · Annals of the American Thoracic Society · doi:10.1513/annalsats.201312-425fr · Cited by 35
Zhao, L., Roche, B. M., Wessale, J. L., Kijtawornrat, A., Lolly, J. L., Shemanski, D., & Hamlin, R. L. (2008) · Life Sciences · doi:10.1016/j.lfs.2007.12.010 · Cited by 34
Yamamoto, Y., Oginö, K., Igawa, G., Matsuura, T., Kaetsu, Y., Sugihara, S., Matsubara, K., Miake, J., Hamada, T., Yoshida, A., et al. (2006) · Hypertension Research · doi:10.1291/hypres.29.915 · Cited by 34
Risk reclassification ability of uric acid for cardiovascular outcomes in essential hypertension
Perticone, M., Tripepi, G. L., Maio, R., Cimellaro, A., Addesi, D., Baggetta, R., Sciacqua, A., Sesti, G., & Perticone, F. (2017) · International Journal of Cardiology · doi:10.1016/j.ijcard.2017.05.051 · Cited by 33
Ambrosio, G., Leiro, M. G. C., Lund, L. H., Coiro, S., Cardona, A., Filippatos, G. S., Ferrari, R., Piepoli, M. F., Coats, A. J. S., Anker, S. D., et al. (2021) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2021.04.001 · Cited by 33
Higher serum uric acid and lipoprotein(a) are correlated with coronary spasm
Nishino, M., Mori, N., Yoshimura, T., Nakamura, D., Matsunaga‐Lee, Y., Taniike, M., Makino, N., Kato, H., Egami, Y., Shutta, R., et al. (2013) · Heart and Vessels · doi:10.1007/s00380-013-0346-x · Cited by 32
Nakagomi, A., Saiki, Y., Noma, S., Kohashi, K., Morisawa, T., Kosugi, M., Kusama, Y., Atarashi, H., & Shimizu, W. (2015) · IJC Metabolic & Endocrine · doi:10.1016/j.ijcme.2015.07.001 · Cited by 32
Zhang, J., Dierckx, R., Mohee, K., Clark, A. L., & Cleland, J. G. F. (2016) · ESC Heart Failure · doi:10.1002/ehf2.12112 · Cited by 32
Allopurinol: novel indications in cardiovascular disease
Struthers, A. D., & Shearer, F. A. (2012) · Heart · doi:10.1136/heartjnl-2012-302249 · Cited by 32
The role of oxidative stress in aortic dissection: a potential therapeutic target
Xu, S., Han, X., Wang, X., Yu, Y., Qu, C., Liu, X., & Yang, B. (2024) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2024.1410477 · Cited by 36
Role of xanthine oxidoreductase in cardiac nitroso-redox imbalance
Τζιόμαλος, Κ. (2009) · Frontiers in bioscience · doi:10.2741/3243 · Cited by 31
Hayashi, K., Kimata, H., Obata, K., Matsushita, A., Fukata, A., Hashimoto, K., Noda, A., Iwase, M., Koike, Y., Yokota, M., et al. (2008) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2007.11.001 · Cited by 31
Renal Reabsorptive Transport of Uric Acid Precursor Xanthine by URAT1 and GLUT9
Arakawa, H., Amezawa, N., Kawakatsu, Y., & Tamai, I. (2020) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b20-00597 · Cited by 31
Fernández-Caggiano, M., Barallobre‐Barreiro, J., Rego‐Pérez, I., Crespo‐Leiro, M. G., Paniagua, M. J., Grille, Z., Blanco, F. J., & Doménech, N. (2013) · Mitochondrion · doi:10.1016/j.mito.2013.03.005 · Cited by 31
Xanthine oxidase activity is influenced by environmental factors in Ethiopians
Aklillu, E., Carrillo, J. A., Makonnen, E., Bertilsson, L., & Ingelman‐Sundberg, M. (2003) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-003-0653-8 · Cited by 31
Implication of xanthine oxidase in muscle oxidative stress in COPD patients
Delample, D., Durand, F., Severac, A., Belghith, M., Mas, E., Michel, F., Cristol, J., Hayot, M., & PREFAUT, C. G. (2008) · Free Radical Research · doi:10.1080/10715760802429039 · Cited by 31
Podagra, Uric Acid, and Cardiovascular Disease
Alderman, M. H. (2007) · Circulation · doi:10.1161/circulationaha.107.728600 · Cited by 31
SALIARIS, A. P., Amado, L. C., Minhas, K. M., Schuleri, K. H., Lehrke, S., John, M. S., Fitton, T. P., Barreiro, C., Berry, C. E., Zheng, M., et al. (2006) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00461.2006 · Cited by 30
Self-citationInoue, T., Ikeda, M., Ide, T., Fujino, T., Matsuo, Y., Arai, S., Saku, K., & Sunagawa, K. (2016) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00044.2016 · Cited by 29
Continuous positive airway pressure decreases myocardial oxygen consumption in heart failure
Kaye, D. M., Mansfield, D. R., & Naughton, M. T. (2004) · Clinical Science · doi:10.1042/cs20030265 · Cited by 30
Badlam, J. B., & Bull, T. (2017) · Therapeutic Advances in Chronic Disease · doi:10.1177/2040622317693218 · Cited by 30
Edwards, R. J., Redwood, S. R., Lambiase, P. D., Tomset, E., Rakhit, R. D., & Marber, M. S. (2002) · Heart · doi:10.1136/heart.88.6.604 · Cited by 29
Therapeutic Development in Cardiac Syndrome X: A Need to Target the Underlying Pathophysiology
Lim, T. K., Choy, A. M., Khan, F., Belch, J. J. F., Struthers, A. D., & Lang, C. C. (2009) · Cardiovascular Therapeutics · doi:10.1111/j.1755-5922.2008.00070.x · Cited by 29
Derks, J. B., Oudijk, M. A., Torrance, H. L., Rademaker, C. M. A., Benders, M. J. N. L., Rosén, K. G., Cindrová‐Davies, T., Thakor, A. S., Visser, G. H. A., Burton, G. J., et al. (2010) · Pediatric Research · doi:10.1203/pdr.0b013e3181ef7780 · Cited by 29
Ventricular dyssynchrony and mechanisms of resynchronization therapy
KASS, D. (2002) · European Heart Journal · doi:10.1016/s0195-668x(02)80025-2 · Cited by 29
Self-citationHuang, Y., Zhang, C., Xu, Z.-Q. J., Shen, J., Zhang, X., Du, H., Zhang, K., & Zhang, D. (2017) · Hellenic Journal of Cardiology · doi:10.1016/j.hjc.2017.01.004 · Cited by 28
Allopurinol and Endothelial Function in Heart Failure
Landmesser, U., & Drexler, H. (2002) · Circulation · doi:10.1161/01.cir.0000024270.37833.f9 · Cited by 28
Fiori, E., Fazio, L. D., Pidone, C., Perone, F., Tocci, G., Battistoni, A., Barbato, E., Volpe, M., Gallo, G., & the Young Group of The Italian Society of Cardiovascular Prevention (SIPREC) (2024) · Journal of Hypertension · doi:10.1097/hjh.0000000000003807 · Cited by 30
Seth, J., Sharma, S., Leong, C. J., & Rabkin, S. W. (2024) · Antioxidants · doi:10.3390/antiox13080955 · Cited by 28
Oxidative Stress and Myocardial Remodeling in Chronic Mitral Regurgitation
Gladden, J. D., Ahmed, M. I., Litovsky, S. H., Darley-Usmar, V. M., McGiffin, D. C., Lloyd, S. G., Gupta, H., Dell’Italia, L. J., Schiros, C. G., & Denney, T. S. (2011) · The American Journal of the Medical Sciences · doi:10.1097/maj.0b013e318224ab93 · Cited by 27
Xanthine Oxidase Inhibition for Hyperuricemic Heart Failure Patients
Givertz, M. M., Mann, D. L., Lee, K. L., Ibarra, J. C., Velazquez, E. J., Hernandez, A. F., Mascette, A. M., & D, E. B. M. (2013) · Circulation Heart Failure · doi:10.1161/circheartfailure.113.000394 · Cited by 26
Characteristic of Metabolic Status in Heart Failure and Its Impact in Outcome Perspective
Tang, H.-Y., Wang, C., Ho, H., Lin, J., Lo, C.-J., Huang, C.-Y., & Cheng, M. (2020) · Metabolites · doi:10.3390/metabo10110437 · Cited by 26
Negi, P. B., Chandra, M., & Misra, M. K. (2006) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-006-9182-y · Cited by 26
Park, H., Kim, H., Sohn, J.-H., Shin, H., Cho, Y., Yoon, H., Nam, C., Hur, S., Kim, Y.-N., Kim, K., et al. (2010) · The Korean Journal of Internal Medicine · doi:10.3904/kjim.2010.25.3.253 · Cited by 26
Bae, M. H., Lee, J. H., Lee, S. H., Park, S. H., Yang, D. H., Park, H. S., Cho, Y., Jun, J. E., & Chae, S. C. (2011) · Circulation Journal · doi:10.1253/circj.cj-10-0952 · Cited by 26
Namai-Takahashi, A., Sakuyama, A., Nakamura, T., Miura, T., Takahashi, J., Kurosawa, R., Kohzuki, M., & Ito, O. (2018) · American Journal of Hypertension · doi:10.1093/ajh/hpy143 · Cited by 26
Nitric Oxide and Oxidative Stress in Cardiovascular Aging
Raju, S. V. Y., Barouch, L. A., & Hare, J. M. (2005) · Science of Aging Knowledge Environment · doi:10.1126/sageke.2005.21.re4 · Cited by 27
Self-citationGladden, J. D., Zelickson, B. R., Guichard, J. L., Ahmed, M. I., Yancey, D. M., Ballinger, S. W., Shanmugam, M., Babu, G. J., Johnson, M. S., Darley-Usmar, V. M., et al. (2013) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00007.2013 · Cited by 25
Graziani, M., Sarti, P., Arese, M., Magnifico, M., Badiani, A., & Saso, L. (2017) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2017/3034245 · Cited by 24
Oxidative Stress and Cell Death in Cardiovascular Disease
Marı́n-Garcı́a, J. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-404599-6.00014-7 · Cited by 26
Xanthine Oxidase Inhibition and Heart Failure
Hajjar, R. J., & Leopold, J. A. (2006) · Circulation Research · doi:10.1161/01.res.0000204557.09610.01 · Cited by 25
Kim, H., Shin, H., Son, J., Yoon, H., Park, H., Cho, Y., Han, C. Y., Nam, C., Hur, S., Kim, Y.-N., et al. (2010) · Congestive Heart Failure · doi:10.1111/j.1751-7133.2010.00144.x · Cited by 24
Kittleson, M. M., & Hare, J. M. (2005) · European Heart Journal · doi:10.1093/eurheartj/ehi321 · Cited by 24
Self-citationEvaluation and Treatment of Gout as a Chronic Disease
Pérez-Ruiz, F., & Herrero-Beites, A. M. (2012) · Advances in Therapy · doi:10.1007/s12325-012-0059-z · Cited by 23
Wong, Y. Y., Handoko, M. L., Mouchaers, K. T. B., de Man, F. S., Noordegraaf, A. V., & van der Laarse, W. J. (2010) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00773.2009 · Cited by 23
Integrated Functions of Cardiac Energetics, Mechanics, and Purine Nucleotide Metabolism
Lopez‐Schenk, R., Collins, N. L., Schenk, N. A., & Beard, D. A. (2024) · Comprehensive physiology · doi:10.1002/j.2040-4603.2024.tb00292.x · Cited by 22
Awad, K., Sayed, A., & Banach, M. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.857364 · Cited by 22
Oxidative Stress and Heart Failure
Marı́n-Garcı́a, J. (2010) · Humana Press eBooks · doi:10.1007/978-1-60761-147-9_10 · Cited by 22
Obstructive sleep apnea and the risk of gout: a population-based case-control study
van Durme, C. M., Spaetgens, B., Driessen, J. H. M., Nielen, J. T. H., Sastry, M., Boonen, A. E. R. C. H., & de Vries, F. (2020) · Arthritis Research & Therapy · doi:10.1186/s13075-020-02176-1 · Cited by 21
Franci, C. R. (2002) · Medicina (Ribeirão Preto) · doi:10.11606/issn.2176-7262.v35i3p277-283 · Cited by 22
Baldasseroni, S., Urso, R., Maggioni, A. P., Orso, F., Fabbri, G., Marchionni, N., & Tavazzi, L. (2010) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2010.08.007 · Cited by 21
Traynham, C. J., Roof, S. R., Wang, H., Prosak, R. A., Tang, L., Viatchenko‐Karpinski, S., Ho, H., Racoma, I. O., Catalano, D. J., Huang, X. S., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0052005 · Cited by 21
Zhou, H., Xu, T., Liu, S.-R., Bai, Y., Huang, X.-Y., Zhan, Q., Zeng, Q., & Xu, D. (2019) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2019.01.001 · Cited by 21
Opie, L. H. (2012) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2011.09.072 · Cited by 19
Roselló‐Lletí, E., Carnicer, R., Tarazón, E., Ortega, A., Gil‐Cayuela, C., Lago, F., González‐Juanatey, J. R., Portolés, M., & Rivera, M. (2016) · Scientific Reports · doi:10.1038/srep24060 · Cited by 20
Oxidative stress and antioxidant capacity: development and prospects
Hu, X., Dong, D., Xia, M., Yang, Y., Wang, J., Su, J., Sun, L., & Yu, H. (2020) · New Journal of Chemistry · doi:10.1039/d0nj02041a · Cited by 21
Sakuma, M., Toyoda, S., Arikawa, T., Koyabu, Y., Kato, T., Adachi, T., Suwa, H., Narita, J.-I., Anraku, K., Ishimura, K., et al. (2022) · PLoS ONE · doi:10.1371/journal.pone.0261445 · Cited by 21
Cardiac Energetic Impairment in Heart Disease and the Potential Role of Metabolic Modulators
Singh, S., Schwarz, K., Horowitz, J. D., & Frenneaux, M. P. (2014) · Circulation Cardiovascular Genetics · doi:10.1161/circgenetics.114.000221 · Cited by 22
Nitroso-Redox Imbalance Affects Cardiac Structure and Function
Karantalis, V., Schulman, I. H., & Hare, J. M. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.12.016 · Cited by 20
Self-citationHyperuricemia and Adverse Outcomes in Cardiovascular Disease
Gavin, A., & Struthers, A. D. (2003) · American Journal of Cardiovascular Drugs · doi:10.2165/00129784-200303050-00001 · Cited by 19
Stone, P. H. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2011.02.072 · Cited by 20
Fan, Y., Zhao, H., Lu, L., & Wu, W. (2025) · Nutrients · doi:10.3390/nu17111855 · Cited by 21
Wu, X., Jian, G., Tang, Y., Cheng, H., Wang, N., & Wu, J. (2019) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2019.12.008 · Cited by 19
Mechanisms of Oxidative Damage and Their Impact on Contracting Muscle
Kerksick, C. M., & Zuhl, M. (2014) · CRC Press eBooks · doi:10.1201/b17442-1 · Cited by 19
Integrated Functions of Cardiac Energetics, Mechanics, and Purine Nucleotide Metabolism
Lopez‐Schenk, R., Collins, N. L., Schenk, N. A., & Beard, D. A. (2023) · Comprehensive physiology · doi:10.1002/cphy.c230011 · Cited by 38
Bonafede, R. J., & Manucha, W. A. (2018) · Clínica e Investigación en Arteriosclerosis · doi:10.1016/j.arteri.2017.12.004 · Cited by 25
Gromadziński, L., Januszko‐Giergielewicz, B., & Pruszczyk, P. (2015) · Advances in Clinical and Experimental Medicine · doi:10.17219/acem/38159 · Cited by 18
Separham, A., Ghaffari, S., Najafi, H., Ghaffari, R., Ziaee, M., & Babaei, H. (2016) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0000000000000409 · Cited by 18
Brombo, G., Bonetti, F., Volpato, S., Morieri, M. L., Napoli, E., Bandinelli, S., Cherubini, A., Maggio, M. G., Guralnik, J. M., Ferrucci, L., et al. (2019) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2019.06.018 · Cited by 18
Fujiwara, T., Saito, S., Osanai, T., Kameda, K., Abe, N., Higuma, T., Yokoyama, J., Hanada, H., Fukui, K., Fukuda, I., et al. (2008) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2008.07.039 · Cited by 18
Plasma Uric Acid as a Prognostic Marker in Patients With Hypertrophic Cardiomyopathy
Zhu, L., Wang, J., Wang, Y., Jia, L., Sun, K., Wang, H., Zou, Y., Tian, T., Liu, Y., Zou, J., et al. (2015) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2015.02.018 · Cited by 18
Yoo, T. W., Sung, K., Kim, Y. C., Hwang, S. T., Oh, S. Y., Shin, H. S., Kim, B. J., Kim, B. S., Kang, J. H., Lee, M. H., et al. (2004) · Korean Circulation Journal · doi:10.4070/kcj.2004.34.9.874 · Cited by 18
Interstitial purine metabolites in hearts with LV remodeling
Gourine, A. V., Hu, Q., Paul Ramm, S., Kuzmin, A. I., Hanafy, N., Davydova, S. A., Zaretsky, D. V., & Zhang, J. J. (2004) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00305.2003 · Cited by 17
Metabolic Approaches for the Treatment of Dilated Cardiomyopathy
Spoladore, R., Pinto, G., Daus, F., Pezzini, S., Kolios, D., & Fragasso, G. (2023) · Journal of Cardiovascular Development and Disease · doi:10.3390/jcdd10070287 · Cited by 15
Bonsu, K. O., Owusu, I. K., Buabeng, K. O., Reidpath, D. D., & Kadirvelu, A. (2016) · Therapeutics and Clinical Risk Management · doi:10.2147/tcrm.s106065 · Cited by 16
Biomarkers in the clinical management of patients with atrial fibrillation and heart failure.
Koniari, I. C., Artopoulou, E., Velissaris, D., Ainslie, M., Mplani, V., Karavasili, G., Kounis, N. G., & Tsigkas, G. (2021) · PubMed Central · doi:10.11909/j.issn.1671-5411.2021.11.010 · Cited by 16
Seki, S., Tsutsui, K., Fujii, T., Yamazaki, K., Anzawa, R., & Yoshimura, M. (2010) · Clinical and Experimental Hypertension · doi:10.3109/10641960903265220 · Cited by 16
Sotoda, Y., Hirooka, S., Orita, H., & Wakabayashi, I. (2017) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.37010 · Cited by 16
In-Hospital Serum Uric Acid Change Predicts Adverse Outcome in Patients With Heart Failure
Yamamoto, H., Nagatomo, Y., Mahara, K., & Yoshikawa, T. (2020) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2020.07.002 · Cited by 15
Xu, H., Liu, Y., Meng, L., Wang, L., & Liu, D. (2021) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2021.639392 · Cited by 15
Ácido úrico: una molécula con acciones paradójicas en la insuficiencia cardiaca
Alcaíno, H., Greig, D. P., Castro, P., Verdejo, H., Mellado, R., Garcı́a, L., Dı́az-Araya, G., Quiroga, C., Chiong, M., & Lavandero, S. (2011) · Revista médica de Chile · doi:10.4067/s0034-98872011000400014 · Cited by 15
BiDil (Isosorbide Dinitrate and Hydralazine)
Carmody, M. S., & Anderson, J. R. (2006) · Cardiology in Review · doi:10.1097/01.crd.0000250840.15645.fb · Cited by 15
Li, X., Kang, S.-T., Li, G., Li, X., & Wang, J. (2011) · Molecules · doi:10.3390/molecules16053580 · Cited by 15
Redox modulation of the inotropic response to dobutamine is impaired in patients with heart failure
Mak, S. S., & Newton, G. E. (2004) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00633.2003 · Cited by 15
Electrochemiluminescent behavior of allopurinol in the presence of Ru(bpy)32+
CHI, Y., XIE, J., & Chen, G. N. (2005) · Talanta · doi:10.1016/j.talanta.2005.08.013 · Cited by 15
Parker, A. M., Lees, J. G., Murray, A. J., Velagic, A., Lim, S. Y., Blasio, M. J. D., & Ritchie, R. H. (2025) · JACC Basic to Translational Science · doi:10.1016/j.jacbts.2025.101345 · Cited by 16
Ning, W., Li, Y., Ma, C., Qiu, L., & Yu, B. (2017) · International Heart Journal · doi:10.1536/ihj.16-444 · Cited by 16
Hyperuricemia and Cardiovascular Disease
Palazzuoli, A., Hashemi, H., Jameson, L. C., & McCullough, P. A. (2017) · Reviews in Cardiovascular Medicine · doi:10.3909/ricm0889 · Cited by 14
Carnicelli, A., Clare, R. M., Chiswell, K., Lytle, B. L., Bjursell, M. K., Perl, S., Andersson, K., Hedman, K., Pagidipati, N. J., Vemulapalli, S., et al. (2020) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2020.04.026 · Cited by 14
Xu, X., Zhao, L., Hu, X. P., Zhang, P., Wessale, J. L., Bache, R. J., & Chen, Y. (2010) · Nucleosides Nucleotides & Nucleic Acids · doi:10.1080/15257771003738683 · Cited by 14
Free Radicals Cardiovascular Diseases: An Update
Bhattacharya, S., Ahmed, K. M., & Chakraborty, S. (2011) · Free Radicals and Antioxidants · doi:10.5530/ax.2011.1.4 · Cited by 14
Nitric Oxide and Cardiobiology‐Methods for Intact Hearts and Isolated Myocytes
Hare, J. M., Beigi, F., & Τζιόμαλος, Κ. (2008) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(08)01221-4 · Cited by 14
Self-citationReactive oxygen species in cardiovascular diseases: an update
Fei, J., Demillard, L. J., & Ren, J. T. (2022) · Exploration of Medicine · doi:10.37349/emed.2022.00085 · Cited by 16
Lack of xanthine dehydrogenase leads to a remarkable renal decline in a novel hypouricemic rat model
Dissanayake, L. V., Zietara, A. P., Levchenko, V., Spires, D. R., Angulo, M. B., El‐Meanawy, A., Geurts, A. M., Dwinell, M. R., Palygin, O., & Staruschenko, A. (2022) · iScience · doi:10.1016/j.isci.2022.104887 · Cited by 15
Allopurinol attenuates L-NAME induced cardiomyopathy comparable to blockade of angiotensin receptor.
Kasal, D. A. B., Neves, M. F., Oigman, W., & Mandarim‐de‐Lacerda, C. A. (2008) · PubMed · doi:10.14670/hh-23.1241 · Cited by 13
Novel pharmacological treatments for heart failure
Tang, W. H. W., & Francis, G. S. (2003) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.12.11.1791 · Cited by 13
MacGowan, G. A. (2005) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-005-2465-9 · Cited by 13
Sung, K., Lo, C., Lai, Y., Tsai, J., Yun, C., Hsiao, C., Kuo, J., Hou, C. J., Hung, T., Su, C., et al. (2020) · PLoS ONE · doi:10.1371/journal.pone.0236173 · Cited by 12
Metadata
- Authors
- Cappola, T. P., Kass, D. A., Nelson, G. S., Berger, R. D., Rosas, G. O., Kobeissi, Z. A., Marbán, E., & Hare, J. M.
- Affiliations
- Johns Hopkins University (US)
- From the Department of Medicine, Division of Cardiology, Johns Hopkins Medical Institutions, Baltimore, Md.
- Venue
- Circulation
- Published
- 2001-11-13
- Volume
- 104
- Issue
- 20
- Pages
- 2407-2411
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2129194977
- Cited by
- 436
- References
- 31
- Citations by year
- 2026: 3 · 2025: 9 · 2024: 12 · 2023: 7 · 2022: 12 · 2021: 14 · 2020: 17 · 2019: 12 · 2018: 12 · 2017: 17 · 2016: 12 · 2015: 17 · 2014: 21 · 2013: 27 · 2012: 25
- FWCI
- 11.93
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Circulation (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Johns Hopkins University
- National Institutes of Health
- National Heart, Lung, and Blood Institute (K08HL003238, K08-HL-03238, R01 HL65455, R01HL065455)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Function and Risk Factors
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiomyopathy and Myosin Studies
- Health Sciences › Medicine › Nephrology › Gout, Hyperuricemia, Uric Acid
- Keywords
- allopurinol, idiopathic dilated cardiomyopathy, xanthine oxidase inhibition, myocardial energy metabolism, myocardial oxygen consumption, stroke work, heart failure treatment, xanthine dehydrogenase, oxidative stress
- MeSH terms
- Allopurinol, Cardiomyopathy, Dilated, Enzyme Inhibitors, Female, Hemodynamics, Humans, Male, Middle Aged, Myocardial Contraction, Myocardium, Oxygen Consumption, Xanthine Oxidase, Oxidative Stress, Ventricular Dysfunction, Left
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
